Look for:

Our offer for

WUXI BIOLOGICS (CAYMAN) INC.


15 minutes delayed
 
ISIN:
KYG970081173
WKN:
-
2024/03/28 09:08:03 15 minutes delayed
Price
14.30 HKD
Difference 3.92% (0.54)

General attributes

ISINKYG970081173
Symbol2269
ExchangeHong Kong Stock Exchange
CurrencyHKD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,198 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)-
Ask (Ask size)-
Open13.80 HKD
High15.00 HKD
Low13.80 HKD
Close (prev. day)13.76 HKD
VWAP14.471849 HKD
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: WUXI BIOLOGICS (CAYMAN) INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download
2024/01/23 en Global Equity Ratings PDF Download
2023/12/21 en Global Equity Ratings PDF Download


2024/03/28 09:08:03 15 minutes delayed
Price
14.30 HKD
Difference 3.92% (0.54)

General attributes

ISINKYG970081173
Symbol2269
ExchangeHong Kong Stock Exchange
CurrencyHKD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,198 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)-
Ask (Ask size)-
Open13.80 HKD
High15.00 HKD
Low13.80 HKD
Close (prev. day)13.76 HKD
VWAP14.471849 HKD
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-67.57%-70.39%-85.41%
Perf (abs.)-29.80-34.00-83.70
Beta0.691.020.63
Volatility95.9977.1673.34
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)13.74 HKD (-)
Ø price 30 days | Ø volume 30 days (pcs.)16.93 HKD (-)
Ø price 100 days | Ø volume 100 days (pcs.)27.97 HKD (-)
Ø price 250 days | Ø volume 250 days (pcs.)37.70 HKD (-)
YTD High | date33.40 HKD (2024/01/11)
YTD Low | date12.94 HKD (2024/03/22)
52 Weeks High | date56.70 HKD (2023/04/14)
52 Weeks Low | date12.94 HKD (2024/03/22)

All listings for WUXI BIOLOGICS (CAYMAN) INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/03/2810:091.665 EUR0.005
Stuttgart2024/03/2810:341.666 EUR0.002
Munich2024/03/2808:161.669 EUR0.001
Hong Kong Stock Exchange2024/03/2809:0814.30 HKD--
Frankfurt2024/03/2808:091.667 EUR0.001
FINRA other OTC Issues2024/03/2614:411.735 USD0.002
Duesseldorf2024/03/2809:301.658 EUR0.002
Berlin2024/03/2810:051.696 EUR0.003

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=143050&ID_TYPE_IMAGE_LOGO=2

Contact Details

WUXI BIOLOGICS (CAYMAN) INC.
- -
108, Meiliang Road, Mashan - 214092 Wuxi
Telefon: +
Fax: +
E-mail: -

PDF Downloads

Company report: WUXI BIOLOGICS (CAYMAN) INC.PDF Download

Company Profile

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.

Members of Management Board

Zhisheng (Chris) Chen, Ph.D.Chairman of Managing Board
Christine Lu-WongMember of Executive Committee
Jijie Gu, Ph.D.Member of Executive Committee
Weichang Zhou, Ph.D.Member of Executive Committee

Board of directors

Ge LiChairman of Supervisory Board
Jue ChenMember of Supervisory Board
Weichang ZhouMember of Supervisory Board
Yi Bing WuMember of Supervisory Board
Jackson TaiMember of Supervisory Board
Kenneth HitchnerMember of Supervisory Board
William KellerMember of Supervisory Board
Yan Ling CaoMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer